Abstract

Osteoporosis, a disease endemic in Western society, typically reflects an imbalance in skeletal turnover so that bone resorption exceeds bone formation. Bone resorption is the unique function of the osteoclast, and anti-osteoporosis therapy to date has targeted this cell. The osteoclast is a specialized macrophage polykaryon whose differentiation is principally regulated by macrophage colony-stimulating factor, RANK ligand, and osteoprotegerin. Reflecting integrin-mediated signals, the osteoclast develops a specialized cytoskeleton that permits it to establish an isolated microenvironment between itself and bone, wherein matrix degradation occurs by a process involving proton transport. Osteopetrotic mutants have provided a wealth of information about the genes that regulate the differentiation of osteoclasts and their capacity to resorb bone.

Keywords

OsteoclastBone resorptionOsteoporosisCell biologyResorptionBone remodeling periodBone remodelingOsteopetrosisChemistryInternal medicineMacrophage colony-stimulating factorOsteoimmunologyOsteoprotegerinMacrophageEndocrinologyRANKLBiologyMedicineReceptorBiochemistry

Affiliated Institutions

Related Publications

Publication Info

Year
2000
Type
review
Volume
289
Issue
5484
Pages
1504-1508
Citations
3910
Access
Closed

External Links

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

3910
OpenAlex

Cite This

Steven L. Teitelbaum (2000). Bone Resorption by Osteoclasts. Science , 289 (5484) , 1504-1508. https://doi.org/10.1126/science.289.5484.1504

Identifiers

DOI
10.1126/science.289.5484.1504